XENTURION, a multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients for population-level translational oncology
Simonetta M. Leto(Candiolo Cancer Institute), Livio Trusolino(University of Turin)
Cited by 3
Related Papers
MET signalling: principles and functions in development, organ regeneration and cancer
|Nature Reviews Molecular Cell Biology|2010|1.2k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k